Catalyst overview
Research summary
This catalyst tracks a Phase 3 data readout for VQW-765 in Social Anxiety Disorder. The expected timing is based on the latest available company guidance and may change.
Ph 2 study data reported 12/2/22, reported low stress level. 2/13/25- Initiate registrational trial in 2025. 10/29/25:- PR No update. 02/11/26:- Ph3 VQW-765 social anxiety trial initiated; results expected by end of 2026. 08/05/26:- Ph3 social anxiety results remain expected in 2026.
Verification
Confirm timing and program details against the company announcement or filing.